WASHINGTON -- A major international study says HIV patients shouldn't delay in seeking treatment: Starting medication soon after diagnosis helps keep people healthy longer. People who started anti- ...
Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
These 48-week data from ARTISTRY-1 build on 24-week results previously presented and show enduring efficacy of bictegravir plus lenacapavir. ARTISTRY-1 is a phase 2, randomized, multicenter study that ...
Despite many oral, once daily, medications for treatment for adolescents with Human Immunodeficiency Virus (HIV), many patients struggle with adherence and alternative options to daily oral therapy ...
Researchers conducted a retrospective, multinational study across 15 European treatment centers to assess the efficacy and tolerability of DTG/3TC vs BIC/TAF/FTC as first‑line therapy in ...
Please provide your email address to receive an email when new articles are posted on . Lamivudine improved visual acuity in patients with center-involved diabetic macular edema. Researchers said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results